KeywordsTRPM8; prostate cancer; migration; chronic cough; TRPV1; TRPM8; TRP antagonists; desensitization; TRPV1; TRPA1; TRPM8; plant-derived chemical; l-glutamate release; spinal dorsal horn; patch-clamp; rat; TRPV1; resiniferatoxin; chronic pain; analgesia; TRPV1; TRPM; TRPA1; obesity; diabetes mellitus; metabolism; glucose homeostasis; TRPV1; capsaicin; vanilloid; pain; nociception; TRPM2; Ca2+ signaling; reactive oxygen species; ROS-coupled diseases; TRPV3; keratinocytes; itch; pain; Olmsted syndrome; capsaicin; pain; nociceptors; TRPV1 receptors; TRPA1; airway inflammation; airway sensory responses; asthma; COPD; cough; TRP channel; pain; nociception; inflammatory pain; neuropathic pain; visceral pain; cancer pain; migraine; dental pain; peripheral sensitization; transient receptor potential; skin; pain; itch; dermatitis; epidermis; TRPA1; TRPV3; hydroxylation; PHD; FIH; HIF; oxygen; hypoxia; transient receptor potential melastatin 8 (TRPM*); pain; menthol; cold hyperalgesia; cold analgesia; mechanical hyperalgesia; migraine; transient receptor potential; TRP; TRPM7; ion channel; cancer; biomarker; therapeutic target; Transient Receptor Potential Channels; TRP; Drug Discovery
